相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical factors related to the efficacy of tyrosine kinase inhibitor therapy in radioactive iodine refractory recurrent differentiated thyroid cancer patients
Kiminori Sugino et al.
ENDOCRINE JOURNAL (2018)
Prolonged duration of response in lenvatinib responders with thyroid cancer
Andrew G. Gianoukakis et al.
ENDOCRINE-RELATED CANCER (2018)
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
Naomi Kiyota et al.
THYROID (2017)
Tumor Volume Doubling Time of Pulmonary Metastases Predicts Overall Survival and Can Guide the Initiation of Multikinase Inhibitor Therapy in Patients With Metastatic, Follicular Cell-Derived Thyroid Carcinoma
Mona M. Sabra et al.
CANCER (2017)
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer
Bruce Robinson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Serum Thyroglobulin Doubling Time in Progressive Thyroid Cancer
Ronja Maria Roessing et al.
THYROID (2016)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
Martin Schlumberger et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
Akira Miyauchi et al.
THYROID (2011)
Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience
Maria E. Cabanillas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
Hendrieke Hoftijzer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
分享论文
